People given a statin had 25% more new cancers

Posted by .(JavaScript must be enabled to view this email address)
Monday, May 28, 2018 11:54 am Email this article

People given the statin, pravastatin (Pravachol), had 25% more cancer than those given a placebo in the PROSPER trial.

• 65% more breast cancer
• 46% more gastrointestinal cancer
• 12% more respiratory cancer
• 41% more other cancers
• and they did not including non-melanoma skin cancer.
  (Previous studies have found that statins increase the risk of non-melanoma skin cancers.)

Reference

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, and Westendorp RG. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 2002 Nov 23; 360(9346): 1623-1630.

Author’s Contact Info

J. Shepherd
University Department of Pathological Biochemistry
University of Glasgow
Royal Infirmary
Scotland, Glasgow, UK
.(JavaScript must be enabled to view this email address)

Articles on the same subject can be found here:

• Cancer

• Cancer, Breast

• Cancer, Colorectal

• Cancer, Lung

• Cancer, others

• Statins